Braidyn Lazenby, Ashley Guidry, Sarah Price, Md Sazzad Mahmud Shuvo, Tursynay Alikhanova, Chloe Morrison, Nicole Davis, Madison Lenard
As GLP-1 receptor agonist medications become more popular, conversations surrounding the medication's use are becoming increasingly more complicated. Emerging research suggests that individuals taking these medications often feel stigmatized. However, understanding how individuals manage stigma through communication is less explored. Using stigma management communication theory, the current study seeks to better understand how individuals communicatively manage stigma surrounding GLP-1 medication use. A reflexive thematic analysis of interviews with GLP-1 users (n = 34) suggests that individuals evaluate their interpretations of both their own self-stigma and the public's understanding of GLP-1 and engage in various different stigma management communication strategies in response. These strategies, while effective for stigma management, may inadvertently contribute to ongoing stigmatizing discourse surrounding GLP-1 use.